BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//eventon.com NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:6ac35fd3b99b7
DTSTAMP:20261005T082907Z
DTSTART:20261015T210000Z
DTEND:20261015T235000Z
LOCATION:
SUMMARY:ARPA-H ASCENT-IBO: Ibogaine for Opioid Use Disorder
DESCRIPTION:ARPA-H is calling on researchers\,  clinicians\,  and innovator
 s across academia\,  industry\,  and government to accelerate early-stage P
 hase 1 and Phase 2 clinical trials of ibogaine as a treatment for opioid us
 e disorder. No federally authorized clinical trials of ibogaine for OUD cur
 rently exist in the United States despite early anecdotal[..]\nhttps://inno
 vate.research.ufl.edu/events/arpa-h-ascent-ibo-ibogaine-for-opioid-use-diso
 rder/
URL:https://innovate.research.ufl.edu/events/arpa-h-ascent-ibo-ibogaine-for-opioid-use-disorder/
END:VEVENT
END:VCALENDAR